TrialJournal of hematology & oncology2017

Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma.

Kai-Chao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.